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CAPSULE SUMMARY 1	  
• The contribution of Human Polyomavirus 6 and 7 to skin diseases remains unclear. 2	  
• Novel strains of Human Polyomavirus 6 and 7 are associated with pruritic dermatoses 3	  
showing dyskeratosis and irregular columns of parakeratosis on histology. 4	  
• Human polyomavirus 6 and 7 associated pruritic and dyskeratotic dermatoses should be 5	  
considered in immunosuppressed patients. Their identification could facilitate the 6	  
characterization and treatment of these diseases.  7	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ABSTRACT 8	  
Background: Human Polyomavirus 6 (HPyV6) and Human Polyomavirus 7 (HPyV7) are shed 9	  
chronically from human skin. HPyV7, but not HPyV6, has been linked to a pruritic skin eruption 10	  
of immunosuppression. 11	  
Objective: We determined whether biopsies showing a characteristic pattern of dyskeratosis and 12	  
parakeratosis might be associated with polyomavirus infection. 13	  
Methods: We screened biopsies showing “peacock plumage” histology by PCR for human 14	  
polyomaviruses. Cases positive for HPyV 6 or 7 were then analyzed by immunohistochemistry, 15	  
electron microscopy (EM), immunofluorescence, quantitative PCR, and complete sequencing, 16	  
including unbiased, next generation sequencing (NGS).  17	  
Results: We identified three additional cases of HPyV6 or 7 skin infections. Expression of T 18	  
antigen and viral capsid was abundant in lesional skin. Dual immunofluorescence staining 19	  
experiments confirmed that HPyV7 primarily infects keratinocytes. High viral loads in lesional 20	  
skin compared to normal skin and the identification of intact virions by both EM and NGS 21	  
support a role for active viral infections in these skin diseases. 22	  
Limitation: This was a small case-series of archived materials. 23	  
Conclusion: We have found that HPyV6 and HPyV7 are associated with rare, pruritic skin 24	  
eruptions with a unique histologic pattern and describe this entity as “HPyV6- and HPyV7-25	  
associated pruritic and dyskeratotic dermatosis (H6PD and H7PD).”  26	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INTRODUCTION 27	  
 Human polyomaviruses (HPyVs) were first described in 1971, when JC polyomavirus 28	  
and BK polyomavirus were identified in immunosuppressed individuals with progressive 29	  
multifocal leukoencephalopathy and nephropathy, respectively 1, 2. In the past decade, an 30	  
additional 11 human polyomaviruses have been described 3.  Of these, several appear to reside 31	  
chronically in human skin—Merkel cell polyomavirus (MCV), trichodysplasia spinulosa 32	  
polyomavirus (TSPyV), HPyV6, and HPyV7. MCV was discovered within, and has been 33	  
strongly linked to the pathogenesis of, a rare but deadly skin malignancy, Merkel cell carcinoma 34	  
(MCC) 4. Trichodysplasia spinulosa polyomavirus has been linked to a folliculocentric eruption 35	  
first described in an immunosuppressed individual 5, 6. 36	  
 HPyVs 6 and 7 are closely related polyomavirus species first identified through rolling 37	  
circle amplification (RCA) of DNA isolated from swabs of healthy human skin 7. They are 38	  
thought to infect the skin in a latent or subclinical manner in the majority of people. In healthy 39	  
individuals with clinically normal skin, previous studies have detected HPyV6 and HPyV7 40	  
sequences from skin swabs in 14-28% and 11-13% of samples, respectively 7, 8. Less is known 41	  
about skin diseases associated with HPyV6 and 7. Recent studies have revealed that HPyV7 42	  
could infect and actively replicate in biopsies taken from immunosuppressed, lung transplant 43	  
recipients. In these patients, the skin infection presented as pruritic, scaly, brown plaques. 44	  
Biopsies from lesional skin showed a characteristic pattern of parakeratosis described as 45	  
“peacock plumage” 9. In contrast to HPyV7, HPyV6 has not yet been linked with specific skin 46	  
disease. Low levels of HPyV6 DNA have been detected in several types of epithelial neoplasms 47	  
and a contribution of HPyV6 to specific epithelial neoplasms has not been excluded10, 11. 48	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 We identified biopsies showing a characteristic pattern of dyskeratosis and parakeratosis, 49	  
previously described as “peackock plumage” for HPyV7 skin infections and investigated 50	  
whether polyomavirus infections might be associated with these eruptions. We identify HPyV6 51	  
and 7 infection in three additional patients with pruritic dermatoses and provide extensive 52	  
evidence for the involvement of these viruses in the pathogenesis of the eruptions 12, 13. Our work 53	  
expands the spectrum of skin diseases associated with HPyV6 and 7 and yields novel insights 54	  
into the biology of these ubiquitous skin polyomaviruses.  55	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METHODS 56	  
This was a retrospective case series of archived skin biopsies. Histologically normal skin and 57	  
archived biopsy samples were obtained through an IRB-exempt protocol. For Patient B, written, 58	  
informed consent was obtained for collecting skin swabs for diagnostic and research purposes. 59	  
Human polyomavirus PCR 60	  
Formalin-fixed, paraffin-embedded (FFPE) sections were deparaffinized with xylene (Sigma, St. 61	  
Louis, MO, USA) and DNA was extracted using the QIAamp DNA FFPE Tissue Kit (Qiagen, 62	  
Hilden, Germany). Typically, PCR was performed on 20ng of genomic DNA with polyomavirus 63	  
screening primers (Table S3). Quantitative PCR (qPCR) was used to determine the copy number 64	  
of HPyV6, HPyV7, and MCV using SYBR green and primers targeting the small T antigen 65	  
region. LINE1 primers were used as a normalization reference. Anonymized skin biopsies from 66	  
8 patients with histologically normal skin were assessed by qPCR as a control. 67	  
Histology, immunohistochemistry, and immunofluorescence studies 68	  
5 µm FFPE sections underwent xylene deparaffinization, rehydration, antigen retrieval, and 69	  
blocking. These slides were stained overnight at 4°C with 6V32 antibody (Buck lab, 1:100) to 70	  
detect HPyV6 and 7 viral capsid protein, 2t10t (Buck lab, 1:100) for HPyV7 small T antigen, or 71	  
1t1 (Buck lab, 1:200) for HPyV6 small T antigen. Slides were then stained with appropriate 72	  
secondary antibody conjugated to HRP (Santa Cruz Biotechnology, Dallas, TX). Lastly, the 73	  
slides were developed with the VECTOR VIP Peroxidase Substrate Kit (Vector Laboratories, 74	  
Burlingame, CA). For co-staining experiments, slides were incubated with HPyV7 antibodies 75	  
and rabbit anti-cytokeratin 10 (clone EP1607IHCY, 1:10,000, Abcam), rabbit anti-cytokeratin 14 76	  
(catlog#PA5-28002, 1:5,000, Thermo Scientific), or rabbit anti-vimentin (clone D21H3, 1:400, 77	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Cell Signaling Technology). Goat anti-mouse Alexa Fluor 546 and goat anti-rabbit Alexa Fluor 78	  
647 were used as secondary antibodies. Confocal images were taken using a Zeiss LSM 880. 79	  
Electron microscopy 80	  
Biopsies were deparaffinized in xylene, dehydrated, and placed in Trump’s fixative. The tissue 81	  
was treated with osmium tetroxide, 2% uranyl acetate, rinsed, and dehydrated in alcohol. The 82	  
tissue was embedded in epoxy resin, and thick and thin sections were generated and stained with 83	  
toluidine blue (with sodium borate). 84	  
HPyV6 and HPyV7 Genome Sequencing 85	  
PCR was performed in a total volume of 50µl with 20ng of DNA using Sapphire Amp Fast PCR 86	  
Master Mix (Takara Bio Inc, Shiga, Japan) and 0.3µM of sequence-specific primers (Table S3).  87	  
Additional HPyV6 sequencing primers were designed with Primer3 to ensure overlapping 88	  
coverage of the genome. Reactions were denatured at 95°C for 5 m, followed by 35 cycles with 89	  
denaturation at 95°C for 1 m, annealing at 56°C for 1 m, and extension at 72°C for 2 m. 90	  
Amplification products were agarose gel-purified with the NucleoSpin Gel and PCR Clean-up 91	  
kits (Machery-Nagel, Düren, Germany) and sent for bidirectional Sanger (GeneWiz, South 92	  
Plainfield, NJ, USA). Methods for unbiased sequencing of circular DNA viruses were previously 93	  
described 7, 14. Briefly, skin swabs were layered onto an Optiprep (Sigma) gradient, centrifuged 94	  
to purify encapsidated virions, Benzonase Nuclease (Sigma) digested, and amplified by RCA 95	  
prior to whole genome sequencing (Illumina MiSeq).  96	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RESULTS 97	  
 The clinical characteristics of the patients, which have been previously reported, are 98	  
summarized in Table I 12, 13. All three patients presented with generalized, scaly, hyperpigmented 99	  
papules coalescing into plaques, which had all been present for at least 12 months. All 100	  
dermatoses were associated with some degree of pruritus (Fig 1A, Table I). While Patient A was 101	  
immunosuppressed from HIV that had progressed to AIDS, Patient C was immunosuppressed 102	  
from a kidney/pancreas transplant. Curiously, Patient B did not report any known 103	  
immunosuppression at the time of initial diagnosis and biopsy in 2008. Importantly, all cases 104	  
were first identified based through biopsies that showed a characteristic histologic pattern—105	  
scattered dyskeratotic cells throughout the epidermis along with irregular columns of 106	  
parakeratosis in the stratum corneum (Fig 1B). This pattern has been described in the literature as 107	  
“columnar dyskeratosis,” “tiered parakeratosis with dyskeratosis,” or “peacock plumage” 9, 12, 13. 108	  
FFPE lesional skin biopsy samples from these patients were screened for known human 109	  
polyomaviruses by endpoint PCR. Sample A amplified HPyV7, while samples B and C 110	  
amplified HPyV6 (Fig 1C). Weaker bands consistent with MCV were detected in samples A and 111	  
C in replicate experiments; however, MCV was not detected by quantitative PCR (data not 112	  
shown). We did identify and screen three additional cases that showed “peacock plumage” on 113	  
histology. However, none of those cases showed evidence of HPyV6 or 7 by PCR (data not 114	  
shown) suggesting that this histologic pattern is not pathognomonic for polyomavirus infection. 115	  
Classically, electron microscopy (EM) has been used to identify virions in tissues with suspected 116	  
polyomavirus infections. EM sections were prepared from samples A and B; insufficient tissue 117	  
remained from sample C for processing. While no viral particles could be identified from sample 118	  
A, the biopsy from patient B revealed cytoplasmic arrays of icosahedral structures approximately 119	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40nm in size, consistent with the reported size of polyomavirus virions (Fig 1D). The viral 120	  
particles in sample B were identified in cells without recognizable features. 121	  
 To confirm the expression of viral proteins in lesional skin, sections were stained with 122	  
antibodies recognizing HPyV6 and HPyV7 capsid and small T antigen proteins. T antigen 123	  
expression was detected in scattered cells throughout all levels of the epidermis. In contrast, 124	  
capsid protein expression appeared to be enriched in the upper layers of the epidermis including 125	  
within parakeratotic cells in the stratum corneum (Fig 2A). Viral capsid could be detected in both 126	  
the nucleus and cytoplasm of infected cells (Fig 2C), while T antigen expression was largely 127	  
limited to the nucleus of infected cells (Fig 2D). At higher magnification, the clear presence of 128	  
desmosomes between infected cells provided histologic confirmation that keratinocytes could 129	  
support active HPyV7 replication (Fig 2D). 130	  
 To better characterize the skin infections caused by HPyV6 and 7, sections from patient 131	  
A were co-stained with antibodies against viral antigens—capsid or small T—and cell-type 132	  
specific proteins—cytokeratin 10 (CK10, a marker of more differentiated keratinocytes), 133	  
cytokeratin 14 (CK14, a marker of basal keratinocytes), or vimentin (a mesenchymal/fibroblast 134	  
marker). The majority of viral antigen positive cells co-stained for CK10 (66.7%) (Fig 3A) or 135	  
CK14 (91.6%) (Fig 3B), while a very small number of cells also appeared to stain positively for 136	  
vimentin (6.4%) (Fig 3C). These findings confirm that HPyV7 productively infects 137	  
keratinocytes. Interestingly, we frequently noted the presence of CK10 negative, capsid positive 138	  
cells in the upper layers of the epidermis (Fig 3A, arrowheads). 139	  
 Because HPyV6 and 7 can be detected at low levels in clinically normal skin from 140	  
healthy individuals 8, we performed quantitative PCR (qPCR) and sequencing to better 141	  
characterize the HPyV6 and 7 infections. DNA extracted from two distinct lesional biopsies from 142	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Patient A revealed an average HPyV7 load of ~2904 copies/LINE repeat (a normalization 143	  
control). In contrast, a collection of skin biopsies from asymptomatic skin donors (n=8) showed 144	  
an average of ~14.3 copies/LINE repeat. Patient B was calculated to have a mean HPyV6 load of 145	  
~1.44×106 copies/LINE repeat, and Patient C, ~2.37×106 copies/LINE repeat. In contrast, control 146	  
samples showed an average of ~31.1 copies/cell (Fig 4A). Thus, the levels of HPyV6 and 7 147	  
detected in multiple independent lesional biopsies were found to be several orders of magnitude 148	  
more abundant than normal skin controls, suggesting a possible pathogenic role for the virus in 149	  
the described rashes. The complete genomes of HPyV7 and 6 (GenBank KX771234-5), 150	  
respectively, were successfully sequenced through primer walking. These sequences clearly 151	  
diverged from published genomes (Fig 4B, Table S1). Specifically, the HPyV6 strain present in 152	  
patient B demonstrated a complex deletion/insertion in the non-coding control region (NCCR) 153	  
along with multiple nucleotide substitutions in the NCCR, major capsid protein VP1, and large T 154	  
(LT) antigen regions. The HPyV7 strain from patient A had a deletion in the NCCR and 155	  
nucleotide substitutions in major capsid proteins VP1/2/3 and LT antigen regions. The possible 156	  
effects of the mutations in the non-coding control region, capsid proteins, and large T antigens 157	  
on viral replication and virulence are yet to be determined. Moreover, swabs collected from 158	  
Patient B in July 2016, after the dyskeratotic dermatosis had resolved, were analyzed through 159	  
unbiased deep sequencing of encapsidated, circular DNA viruses 7, 14. In addition to abundant 160	  
reads representing the complete genomes of nine human papillomaviruses and a MCV strain 161	  
(GenBank KX781279-88), 121 reads matching HPyV6 isolate UTSW6.1 were observed (Fig 162	  
4C). The results show that patient B continued to shed HPyV6 (alongside other typical members 163	  
of the human skin virome) after resolution of symptoms.  164	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DISCUSSION 165	  
Ho et al9 first associated HPyV7 infection with pruritic rashes in immunosuppressed transplant 166	  
patients with a characteristic “peacock plumage” histology. Our study confirms and extends 167	  
these seminal findings by linking HPyV6 with similar rashes. This study also broadens the range 168	  
of immunosuppressed states that may allow for HPyV7 infection from iatrogenic 169	  
immunosuppression from organ transplantation to the immunocompromised state of HIV 170	  
infection.  Interestingly, the HIV/AIDS patient (Patient A) was initially diagnosed with a variant 171	  
of epidermodysplasia verruciformis13. While we can not exclude that papillomavirus co-infection 172	  
contributed to some of the patient’s findings, our analyses indicate that HPyV7 infection alone 173	  
could be sufficient to explain the observed clinical and histologic changes. It is also worth noting 174	  
that Patient B in this study was not reported to be immunosuppressed at the time of the original 175	  
biopsies. However, we speculate that the patient may have an uncharacterized, acquired 176	  
immunosuppression based on his recent, frequent hospitalizations for severe infections. 177	  
These studies also expand our understanding of the biology of HPyV7. First, we 178	  
definitively identify keratinocytes as the primary targets of HPyV7 infection in the skin. While 179	  
MCV, TSV, HPyV9, and HPyV10 DNA can be detected on the skin8, 15, no other 180	  
polyomaviruses have been demonstrated to infect non-follicular keratinocytes. Given the 181	  
detection of HPyV6 and 7 in other tissues16, 17, it is likely that HPyV6 and 7 can infect or remain 182	  
latent in non-epidermal tissues, as is the case for other polyomaviruses. Our studies also suggest 183	  
that like other human polyomaviruses, HPyV6 may persist as a latent infection in patients 184	  
without clinical evidence of disease. Specifically, Patient B possessed detectable levels of 185	  
HPyV6 on his skin despite the fact that his pruritic dermatosis had resolved. How 186	  
polyomaviruses, including HPyV6 and 7, maintain latency remains unclear. The decreased 187	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expression of CK10 in some HPyV7-infected keratinocytes, in concert with the notable 188	  
dyskeratosis in these infections, suggests that latent infections might be maintained, in part, 189	  
through the inhibition of normal keratinocyte differentiation. Moreover, the numerous sequence 190	  
changes in the strains identified in our work could also contribute to the virulence and/or 191	  
persistence of these strains and deserve further investigation. 192	  
Because our case series is very small and largely retrospective in nature, additional cases 193	  
showing HPyV6 and 7 infection are necessary to confirm our findings. Moreover, the limited 194	  
number of cases prevents us from definitively assigning causation to HPyV6 and 7. We speculate 195	  
that additional cases of H6PD and H7PD will be identified based on the characteristic “peacock 196	  
plumage” histologic pattern, in which nucleated, eosinophilic keratinocytes are present within 197	  
the stratum corneum. In future studies, it may be worthwhile investigating whether patients 198	  
previously diagnosed with epidermodysplasia verruciformis show clinical or histologic changes 199	  
consistent with the polyomavirus infections described here. Cases showing the characteristic 200	  
histology could then be further screened for the presence of human polyomaviruses, especially 201	  
HPyV6 and 7. 202	  
In summary, we provide multiple lines of evidence suggest that highly active HPyV6 and 203	  
7 infections are associated with skin disease, including high viral copy number in lesional skin, 204	  
the expression of viral proteins by IHC in dyskeratotic keratinocytes, and the detection of 205	  
encapsidated virions by both electron microscopy and unbiased sequencing. Given the 206	  
characteristic clinical and histologic presentation of this rash, we propose that this skin disease 207	  
be described as HPyV6- and HPyV7-associated pruritic and dyskeratotic dermatosis (H6PD and 208	  
H7PD). This rare condition could be included in the differential diagnosis of immunosuppressed 209	  
patients with recalcitrant, pruritic rashes. The identification of additional cases would be an 210	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important step toward improving our understanding of human polyomavirus biology and 211	  
ultimately developing better treatments for their associated diseases. 212	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Table I. Clinical characteristics of patients with HPyV6 and 7 associated dermatoses. 264	  
 265	  
Patient Age/Sex Immunosuppresion Pruritus Clinical History 
A 36/F HIV/AIDS severe Worsening pruritic rash over 12 
months; HPV-5, HPV-111, 
HPV-120, HPV-124, HPV 
isolate FA-88 positive; patient 
deceased 
B 54/M None at the time of 
diagnosis 
present Initial worsening over 2yrs 
followed by resolution over 
several years; HPV- by PCR; 
HIV negative; prominent 
palmar involvement; recent 
hospitalizations for sepsis, 
parapharyngeal abscess, 
pneumonia 
C 52/M Kidney/pancreas 
transplant 
(tacrolimus/rapamycin) 
present Pruritic rash over >2yrs; HPV-; 
prominent palmar involvement; 
patient deceased 
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 266	  
Figure 1. HPyV6 and 7 are associated with a pruritic and dyskeratotic dermatosis. (A) Generalized, 267	  
hyperpigmented, scaly eruptions in Patient B, with no known immunosuppression, and Patient C, a 268	  
kidney/pancreas transplant patient, (Pock and Stork 2010). Images from an HIV/AIDS patient (Patient A) 269	  
have previously been published (Champagne 2015);  (B) From Patient B, on routine H&E sections, there 270	  
is mild acanthosis and papillomatosis (top, H&E, 40X total magnification); several dyskeratotic cells are 271	  
noted in the superficial epidermis (arrows), with eosinophilic, nucleated keratinocytes forming irregular 272	  
columns of parakeratosis (arrowheads) in the stratum corneum (middle, H&E, 200X). From Patient C, an 273	  
area with prominent columnar dyskeratosis showing dyskeratotic cells (arrows) and nucleated 274	  
keratinocytes in the stratum corneum (arrowheads) (bottom, H&E, 200X) (C) PCR for human 275	  
polyomaviruses yielded specific bands for HPyV7 (arrow) and HPyV6 (black arrowhead). (D) Electron 276	  
microscopy of affected cells revealed numerous cytoplasmic ~40-nm icosahedral virions from Patient B 277	  
(18000X, original direct magnification).   278	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 279	  
Figure 2. Immunohistochemistry against HPyV6 and 7 viral proteins. (A) Sample A shows capsid 280	  
(6V32) expression in the nucleus and cytoplasm of affected cells. HPyV7 small T antigen (2t10t) is 281	  
detected more strongly in the nuclei of affected cells. Samples B and C show capsid and HPyV6 small T 282	  
antigen (1t1) in affected cells (insets, 200X). (B) High power images of the immunohistochemical stains 283	  
show capsid protein expression in the nucleus and cytoplasm of the keratinocytes with viral cytopathic 284	  
changes (left, oil immersion, 1000X). (C) Small T antigen is detectable in adjacent cells attached by 285	  
desmosomes (right, arrow, oil immersion, 1000X) confirming their identity as keratinocytes.  286	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 287	  
 288	  
 289	  
Figure 3. HPyV7 infects keratinocytes. (A) Dual immunofluorescence (IF) staining for Cytokeratin 10 290	  
(CK10) and capsid (6V32) confirms that most capsid expressing cells also express CK10 (arrows, 400X). 291	  
However, there are several cells in which the expression of CK10 is undetectable (arrowheads). (B) Dual 292	  
IF staining for Cytokeratin 14 (CK10) and capsid (6V32) confirms that almost all capsid expressing cells 293	  
also express CK14 (arrows, 400X). (C) Dual IF staining for Vimentin and small T antigen (2t10t) 294	  
identifies rare T antigen expressing cells that also express vimentin (arrow, 400X). (D) Quantitation of 295	  
dual IF staining images. 296	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 298	  
Figure 4. Novel strains of HPyV6 and 7 are abundant in lesional skin but can still be detected in 299	  
asymptomatic patients. (A) Quantitative PCR comparing levels of HPyV6 and 7 detected in normal skin 300	  
compared to lesional skin normalized to LINE-1 repeats.  (n=independent biopsy; error bars=SD; t-test; 301	  
**p≤0.01, ***p≤0.001, ****p≤0.0001). (B) Schematic of HPyV7 isolate from Patient A 302	  
(HPyV7_UTSW7.1) and HPyV6 isolate from Patient B (HPyV6_UTSW6.1) with labels indicating the 303	  
approximate position of nucleotide and AA changes. Cladograms (left) indicate the phylogenetic 304	  
relationship of the current strains with previously sequenced strains. (C) Patient B possessed subclinical 305	  
infections of HPyV6 isolate UTSW6.1 and MCV isolates after clinical symptoms had resolved in 2016. 306	  
Pie chart indicates the proportion of reads (300bp or longer) corresponding to the indicated virus.   307	  
	  	   22 
SUPPLEMENTAL MATERIALS 308	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Table S1. Viral Genomic Changes 310	  
 311	  
Location HPyV7_UTSW7.1 HPyV6_UTSW6.1 
NCCR n.148del2 Ins/del with mult. nt changes 
 n.C202G   
Early (sT, LT) n.G2594A  (p.Thr!Ile) n.A2567T 
 n.C2877T  (p.Val!Ile) n.T2923C  (p.Ile!Val) 
 n.C3751T n.G2927C  (p.Asp!Glu) 
 n.A3889G n.A3026G 
  n.G3402T  (p.Thr!Lys) 
  n.T3479A; n.C3478T  
(p.Ala!Thr) 
  n.C3756T  (p.Arg!Lys) 
  n.A3831G  (p.Ile!Thr) 
Late (VP1/2/3) n.G771C n.A920G 
 n.A1016G n.C1449A 
 n.A1404C  (p.Glut!Asp) n.1500insCAC  (p.insThr) 
 n.G1929T n.G1661A  (p.Arg!Lys) 
  n.T2034C 
Other n.C4303A n.G2422C  (p.Glu!Gln) 
	  312	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Table S2. Primers Used in the Study 314	  
	  315	  
Screening Primers
Polyomavirus Primer Name Sequence (5' to 3') Reference
JC, BK (Outer) P-3 GTATACACAGCAAAGGAAGC Giraud et al., 2008
P-4 GCTCATCAGCCTGATTTTGG
JC, BK (Inner) P-1 AGTCTTTAGGGTCTTCTACC Giraud et al., 2008
P-2 GGTGCCAACCTATGGAACAG
KI, WU KIPyV2263.F TTGGATGAAAATGGCATTGG Giraud et al., 2008
KIPyV2404.R TAACCCTTCTTTGTCTAAAATGTAGCC
MCV MCV.F GGAATTGAACACCCTTTGGA Ho et al., 2014
MCV.R CTACAATGCTGGCGAGACAA
HPyV6 HPyV6.F GGCATTTGCAGGAACTGATT Ho et al., 2014
HPyV6.R AAGTTGAATGCCACCCTGAG
HPyV7 HPyV7.F AAACTCTGGCCCCAAAAACT Ho et al., 2014
HPyV7.R GAGATCCCCAGAAAATGCAA
TSPyV TSA.F TGAAGGCCTATTTTGCAGGT Ho et al., 2014
TSA.R AGCCAGGTAGGCTCATGGTA
HPyV9 HPyV9.F AGAGGCGCAGCAAACTTAAA Ho et al., 2014
HPyV9.R TGGTGGATATCCTGATTGCAT
STL, MW STLMWScreen.F GRATGAAAYRCWWTTACAGGTTGCCACC Lim et al., 2013
STLMWScreen.R GTGGWAAAACAACTGTAGCWGCTGC
HPyV12 HPyV12.VP1731.F GTGGGAAGCTGTCAGTGTGA Korup et al., 2013
HPyV12.VP1868.R CCACCTACTGCAAACATGTG
Sequencing Primers
Polyomavirus Primer Name Sequence (5' to 3') Reference
HPyV6 H6_4628R TGAAGACATTTGGTCCCTC Schowalter et al., 2010 
H6_395L AAAGCAGCAGCAGACTGTAGAGCC
H6_160R ACTGAGGTTGACCACCGTTG
H6_992L ACTCCATTGCCCTCAAAC
H6_679R AAGTTTGGTCTTGGGGAGG 
H6_1465L GGCTTCCCAAACCAACAAAGTATC
H6_2032L CTCTCCTCTGTCTGAAGTGAAC
H6_3110R CAGCAGCCAATGTTGTTTTG 
H6_4117L AATAGAGGCTGGGACGATG
H6_3774R GCATTTAGCATAGCAGACACTC
H6_4539L TTGCCTTCTCAAAAAGGAGC
H6_1068F GGGCCCTGTTAGAAGGAAGG this study
H6_1710F AGCCCCTTGGATGTCATTGG
H6_1710R GAGGGGTTTACAGCTCACCC
H6_2384F GCAAATTTGTTTGGGCCTCCA
H6_2384R CAAGGTGTCCCAGCTGTTT
H6_2872F CCTCTGGCAATTCTGGCCTT
H6_2872R AGCAGCACAAAGAAGGGTGT    
H6_3587F CAGCTTGCTGGATCATTGGC 
H6_3857R GGTTTGGCCTACCTGTGGAA
H6_4143F GAGAGTTGCCTTCACCAGGG
H6_4143R ATGGATCGCCTTTTAGCCAGAG
H6_4716F ACATTTGGTCCCTCAGGGTG
H6_4716R TGGATCGCCTTTTAGCCAGAG
HPyV7 contig1.F TAGAAGGGTGGAGGCAAATG  Ho et al., 2014
contig1.R CTTCATTGGACACTGCCAGA
contig2.F AGCCCTTCAAAGTGCTGCT  
contig2.R CTACTCAACAGGCTTGCCAAT
contig3.F TTCCTACTACAGAACAGGAAGAGAG
contig3.R TGTGTCCTCCGTGAGTGGTA
contig4.F GGAAATGGACCCACACAAAA  
contig4.R ACTTGCTTTCTGAGGGCTTG
contig5.F TGAAGCCCTAGAAGGTCCAG
contig5.R GCTGCATTTGCTCCATTGTA
contig6.F CAGAAGCCACAGGTGCAG 
contig6.R GAACCAGTGTCTGACTTTGTTGA
contig7.F CCATATGACACCCACTGTTCA 
contig7.R CAGCTGCCATTCTGGATTTA
contig8.F CAATAGCACATCCCAGTTCAAA 
contig8.R TTTGCTACAGAGCCATCACTG
contig9.F TGCTTCTCATGGTGTTGGTG
contig9.R GCCATGCCACTTTAGGTAACA
contig10.F TTCTCATAAAGCAACATACTTTTCTCA 
contig10.R CACTTTTTGGCGGGCTAAT
qPCR primer
Polyomavirus Primer Name Sequence (5' to 3') Reference
HPyV6 HPyV6qPCR.F TAGCACTTGTAGCACCAG Schowalter et al., 2010 
HPyV6qPCR.R ATGCCTTCATTGCCTTCT
HPyV7 HPyV7qPCR.F TCTAACCTTATGCTGTATG
HPyV7qPCR.R GGTAGAGATGAAGTCAAG
MCV MCVqPCR.F GGTGCAGATGCAGTAAGCAG
MCVqPCR.R TTGTCTCGCCAGCATTGTAG
LINE1 LINE1qPCR.F TTGCGGCATTATTCACAATAGC Yu et al., 2008
LINE1qPCR.R GTGCCACATTTTCTTAATCCAGTCT
